Low-Dose vs High-Dose Paclitaxel-Coated Balloons for Femoropopliteal Lesions: 2-Year Results From the COMPARE Trial.

[1]  H. Krankenberg,et al.  Femoropopliteal Paclitaxel-Eluting Stents in the Real World: Does CAPSICUM Add Hot Chili or Sweet Pepper? , 2022, JACC: Cardiovascular Interventions.

[2]  J. Beckman,et al.  Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD. , 2021, Journal of the American College of Cardiology.

[3]  W. Gray,et al.  Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial. , 2021, JACC. Cardiovascular interventions.

[4]  M. Brodmann,et al.  1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon. , 2021, JACC. Cardiovascular interventions.

[5]  E. Secemsky,et al.  The Safety of Paclitaxel-Coated Devices for Patients with Peripheral Artery Disease , 2021, Current Cardiology Reports.

[6]  P. Danielsson,et al.  Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease. , 2020, The New England journal of medicine.

[7]  D. Scheinert,et al.  Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial. , 2020, Radiology.

[8]  D. Scheinert,et al.  COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions , 2020, European heart journal.

[9]  E. Ducasse,et al.  Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. , 2019, Journal of vascular surgery.

[10]  I. Porto,et al.  Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study. , 2019, Journal of the American College of Cardiology.

[11]  D. Scheinert,et al.  Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease. , 2019, Journal of the American College of Cardiology.

[12]  S. Spiliopoulos,et al.  Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials , 2018, Journal of the American Heart Association.

[13]  Xin Jia,et al.  Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I. , 2018, JACC. Cardiovascular interventions.

[14]  J. Granada,et al.  Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results. , 2018, JACC. Cardiovascular interventions.

[15]  Hong Wang,et al.  Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study Long Lesion Imaging Cohort , 2018, Circulation. Cardiovascular interventions.

[16]  I. Ott,et al.  Two-Year Clinical Outcomes of the CONSEQUENT Trial: Can Femoropopliteal Lesions be Treated with Sustainable Clinical Results that are Economically Sound? , 2018, CardioVascular and Interventional Radiology.

[17]  D. Scheinert,et al.  Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency , 2017, Circulation. Cardiovascular interventions.

[18]  S. Parikh,et al.  Mechanisms Underlying Drug Delivery to Peripheral Arteries. , 2017, Interventional cardiology clinics.

[19]  D. Scheinert,et al.  Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry. , 2016, JACC. Cardiovascular interventions.

[20]  S. Spiliopoulos,et al.  Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries , 2016, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[21]  Hong Wang,et al.  Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA. , 2015, Journal of the American College of Cardiology.

[22]  D. Scheinert,et al.  Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. , 2015, The New England journal of medicine.

[23]  P. Hayes,et al.  Atherectomy for peripheral arterial disease. , 2014, The Cochrane database of systematic reviews.

[24]  C. Claussen,et al.  Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. , 2008, The New England journal of medicine.

[25]  D. Bloch,et al.  Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.